Search results for:
Photodisinfection for Biofilm Joint Infections
Photodisinfection found to eradicate biofilms associated with periprosthetic joint infections Vancouver, British Columbia, Canada - January 17, 2023 Periprosthetic joint infections are life-threatening and extremely hard-to-treat. The annual cost of treating periprosthetic joint infections in the US is $1.62 billion, with costs projected to [...]
Steriwave receives regulatory approval in Mexico
Steriwave receives regulatory approval in Mexico Vancouver, British Columbia, Canada - December 12, 2022 Photodisinfection kills all types of pathogens, including viruses, bacteria and fungi without using antibiotics Mexico’s Health Authority (COFEPRIS) has approved the sale and use of Ondine Biomedical’s Steriwave™ photodisinfection technology, which [...]
Ondine receives funding for meat photodisinfection
Ondine Biomedical receives Agriculture and Agri-Food Canada (AAFC) funding to improve food security and increase shelf-life through photodisinfection Vancouver, British Columbia, Canada - December 5, 2022 Funding of up to $735,000 towards development of prototype of novel photodisinfection application for use in food production. Up [...]
Ondine reports full results from Phase 2 nasal photodisinfection trial
Ondine Biomedical reports the full results from Phase 2 nasal photodisinfection trial Vancouver, British Columbia, Canada - December 5, 2022 Full results confirm that a single, 5-minute treatment of nasal photodisinfection significantly reduces Staphylococcus aureus, a major cause of surgical site infections, in pre-surgical patients. [...]
Ondine presents new efficacy data against MRSA
Ondine Biomedical presents research showing its Steriwave photodisinfection treatment is highly effective against multidrug-resistant strains of MRSA Vancouver, British Columbia, Canada - October 19, 2022 Photodisinfection technology shows great promise as a new method for fighting drug-resistant infections amidst rising rates of antimicrobial resistance. Ondine [...]
Steriwave™ cuts SSI risk by 47% at major hospital
New study shows nasal photodisinfection cuts surgical site infection risk by 47% and mortality by nearly 60% Vancouver, British Columbia, Canada - October 19, 2022 Surgical site infections reduced by an average of 47% across all surgery types (P=0.01). Most significant impact seen in cardiac [...]
The Ottawa Hospital pilots pre-surgical nasal disinfection
The Ottawa Hospital pilots pre-surgical nasal disinfection for all spine surgery patients to reduce infections Vancouver, British Columbia, Canada - September 23, 2022 The Ottawa Hospital has chosen to use photodisinfection technology developed by Canadian life sciences company, Ondine Biomedical. Nasal decolonization has been recommended [...]
Photodisinfection successfully eradicates pathogens associated with replacement joint infections
New research shows photodisinfection successfully eradicates pathogens associated with replacement joint infections Vancouver, British Columbia, Canada - September 20, 2022 A research team in Zurich, Switzerland has presented results from an in vitro study showing that photodisinfection achieved >99.99% eradication (4-7 log10 kill) of the [...]
Ondine’s photodisinfection kills ESKAPE pathogens
Data presented at World AMR Congress shows Ondine Biomedical’s photodisinfection effective against antibiotic-resistant ESKAPE pathogens Vancouver, British Columbia, Canada - September 7, 2022 Canadian life sciences company, Ondine Biomedical Inc. (LON: OBI), this week presented an in vitro study at the World Anti-Microbial Resistance [...]
Ondine reports successful US Phase 2 trial data
Ondine Biomedical reports successful topline data from Phase 2 nasal photodisinfection trial Vancouver, British Columbia, Canada - September 6, 2022 Results show a single, 5-minute treatment of nasal photodisinfection significantly reduces Staphylococcus aureus, a major cause of surgical site infections, in pre-surgical patients Top line results [...]
For Media Information
Simon Vane Percy
Amanda Bernard
